Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2007
May 1, 2007
- Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
- Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
- deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
- AVI BioPharma Reports Positive Pre-Clinical Influenza Data
- CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
- Peramivir Protects Mice From Lethal H5N1 Infection
- Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions
- First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
- New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
- Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
- Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
- Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
- FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
- Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
- Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
May 2, 2007
- Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show
- Phase III Data on Safinamide in Parkinson’s Disease Presented at American Academy of Neurology 59th Annual Meeting
- MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
- Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
- Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
- Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published
- Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
- Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than Vaccines Used in Previous Years
- FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
- Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
- Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
- Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
- Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
- Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
- St. Jude Study Shows Effectiveness of Peramivir in Prevention of Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection
- Cethromycin Shown Effective Against Anthrax in Study
- New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
- Pluristem to Present Two Scientific Posters at the International Society for Cellular Therapy
- LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization
- New Data Shows Once a Day Lamictal XR is Effective in Treating Patients with Partial Seizures
May 3, 2007
- Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
- Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
- Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
- Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabri in Patients with Multiple Sclerosis
- Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study
- YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
- Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
- Quest PharmaTech's Prostate Cancer Program Update
- Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
- Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid
- Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
- Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
- Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
- ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
- Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
- Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
- Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
- EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
- Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug
May 4, 2007
- Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
- Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
- Argos Therapeutics Presents Immunosuppression Data for Soluble CD83 at the American Society of Transplantation Congress 2007
- Data to be presented at AAN Meeting -Study results of drug candidate for MS
- Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
- Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease
- Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
- Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
- Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
- PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
- Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of Neurology Annual Meeting
- Lux Biosciences' Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
- Independent publication supports the profile of CeNeS phase II compound, CNS 5161
- Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
- Isotechnika's Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 7, 2007
- IR BioSciences Announces Promising Data from Study of Its Compound Homspera
- NanoViricides Drugs Found To Be Highly Effective Against Most Recent Strain of the H5N1 Avian Flu Virus
- Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
- Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
- Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
- Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting
- Pacgen Announces Positive Results from Phase I/II Trial of Novel Antifungal Drug
- Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
- Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies
- OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology
- FDA Advises Manufacturers to Test Glycerin for Possible Contamination
- Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In Absolute Bioavailability Study
- Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
- Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
May 8, 2007
- Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
- Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies' Annual Meeting
- King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
- ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
- AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain
- Data Show FluMist May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
- MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
- Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
May 9, 2007
- Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
- FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
- Discovery's KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
- Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction
- Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference
- Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's Investigational Drug to Treat Cocaine and Methamphetamine Addiction
- VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
- Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill
May 10, 2007
- Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas
- New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine
- Gardasil Demonstrates Up to 100% Efficacy
- Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
- New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
- Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor AP 12009 to be Presented
- GenVec Presents Research on New Ad35 Adenovector at ARVO
- FDA Announces Results of Investigation Into Illegal Promotion of OxyContin by The Purdue Frederick Company, Inc.
- KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
- 2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion
May 11, 2007
May 14, 2007
- GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
- Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
- Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
- Global Rabies Treatment May be Possible with NanoViricides Drugs
- Sciele Pharma Announces Successful Completion of New Sular Formulation Clinical Trial Program
- BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
- Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
- Nationally Recognized Researchers Provide First Economic Projections of Social Value of Treatments That Delay Onset of Alzheimer's Disease
- Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
- New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
May 15, 2007
- Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in Preclinical Studies
- SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
- Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
- SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
- New Survey Finds Troubling Data on American Asthma Sufferers
- Gemin X Biotechnologies Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma
- Boston Scientific Announces Schedule for EuroPcr 2007
- Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy
- Geron Corp. Licensee TA Sciences Announces Proven Anti-Aging Benefits of TA-65, Their Telomerase Activator: Improved Immune Function, Vision, Skin, Male Sexual Function, Well-Being & Energy are Strongest Claims
- First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
- RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
May 16, 2007
- Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
- Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
- AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV Irradiated Skin Cells
- The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
May 17, 2007
- Oxford Biomedica Announces That Phase II Results with Hi-8 Mel in Melanoma Will Be Presented at American Association of Immunologists Meeting
- AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin Cells Have the Ability to Recognize, Transport and Utilize L-ergothioneine (EGT) As A Protector Against Oxidative Damage
- Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
- DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
- Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
- ProtoKinetix' AAGP Improves Effectiveness of Diabetes Treatment
- Pro-Pharmaceuticals to Present Abstract at the International Society of Oncodevelopmental Biology and Medicine Conference
- Salix Pharmaceuticals Previews Digestive Disease Week 2007
- Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
- Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007
- BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences
- Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
May 18, 2007
- DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
- Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
- Staphylococcus aureus vaccine development on track ? safe and immunogenic in Phase I clinicaltrials
- Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
- Migenix to Present Celgosivir Phase II Hepatitis C Results at Digestive Disease Week 2007
- Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
- Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
- Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007 American Psychiatric Association Annual Meeting
May 21, 2007
- Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
- InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive Disease Week Meeting
- Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
- Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron
- Dendreon Announces Presentation of Data at American Urological Association Annual Meeting
- New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
- New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
- Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
- King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For 24-hour Blood Pressure Control
- Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin in Complicated Urinary Tract Infections and Acute Pyelonephritis
- Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
- Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
- Efficacy and Safety Profile of Basilea's Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
- Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril
- Microbia Announces Positive Phase 2 Results for Its Investigational Compound Linaclotide
- Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
- New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
- Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
- Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
- CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
- Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
- Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer
- Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
- Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
- Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
- Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
- Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
- Alterations in Intestinal Serotonin in Irritable Bowel Syndrome and Dyspepsia
- FDA Issues Safety Alert on Avandia
- Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder
- Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered ''Cured''
May 22, 2007
- Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
- Comptroller General Announces Appointments to the Medicare Payment Advisory Commission
- Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
- New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
- Organon's Asenapine Effective in a Phase III Study for the Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA Meeting
- Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
- UCB Presents Long-Term CImzia Data in Crohn's Disease
- New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
- Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW
- PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
- New Analysis of Data Shows Treatment With Abbott's Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease
- Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
- Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
- Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
- BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
- NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
- Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA
- Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
- Inovio: DNA delivery technology shows positive human results
- Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
- ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
- NCCN Updates Esophageal and Gastric Cancer Guidelines
- ACC Sanctions Leon
- Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease
- New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
- Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
- Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
- Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab
- Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
- Medtronic Announces Positive Nine-Month Results for Endeavor Resolute Next Generation Drug-Eluting Stent at EuroPCR
- SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
- Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
- XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
- Antipsychotic Iloperidone Results Show Favorable Akathisia Profile
- New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
- Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
May 23, 2007
- Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
- Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
- Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
- Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
- AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
- ProtoKinetix's AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
- Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
- Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
- MIV Therapeutics Announces Renowned Researcher to Detail Milestone Pre-Clinical Results at Prominent International Conference EuroPCR 2007
- CytoGenix to Present at 2007 International DNA Vaccines Conference in Spain
- Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
- Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.
- Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
- Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
- Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
- Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
- New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
- Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
- Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
- VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
- New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate
- CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
- Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
- Acusphere Announces Publication on Imagify in the Journal Future Drugs
- New Data Focuses on Abuse of Stimulant Medication
- Synta Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the ASCO Annual Meeting
- Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
- Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
- Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
- 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
May 24, 2007
- Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
- La Jolla Pharmaceutical Company Reports Riquent Well Tolerated in Three Studies at International Lupus Congress
- Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
- ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007 Conference
- Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
- Inovio Biomedical's DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
- Long-term Treatment with Vyvanse (lisdexamfetamine dimesylate), the First Prodrug Stimulant, Demonstrates Significant Efficacy in Children with ADHD
- RX100 Rescues Life if Administered 3, 6, 12, or Up to 24 Hours After Exposure to Lethal, Whole-Body Radiation!
- In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
- Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis
- Proteolix Announces Interim Clinical Results with Carfilzomib to be Reported at ASCO 2007 Annual Meeting
- MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
- Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting
- ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
- Generex Biotechnology Vaccine Strategy Presented at International Conference in London
- Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
May 25, 2007
- GTx Announces Presentation of Ostarine and Acapodene Data at 2007 ASCO Annual Meeting
- Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
- Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
- Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
- Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
- Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
- Viventia Biotech Reports Final Vicinium Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting
- Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
- Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study Results at the American Society of Clinical Oncology Annual Meeting
- Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
May 29, 2007
- Onyx Pharmaceuticals Announces an Analyst Briefing
- New Pfizer Oncology Data Across Numerous Cancer Types to be Presented at ASCO
- Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat
- Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
- HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
- Antidepressant Use May Boost Fracture Risk, From Harvard Women's Health Watch
- Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
- Alfacell and University of Bath Collaborators Identify Structure of Amphinase
- Mild Asthma, a Revolutionary Therapy from Italian Research
- Velcade (Bortezomib) for Injection to be Featured at Upcoming American Society of Clinical Oncology Meeting
- DP-b99 Phase IIb Trial Results to be Presented at the European Stroke Conference
- Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
- Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
May 30, 2007
- Introgen's Advexin Demonstrates Clinical Benefit in Inherited Cancer
- Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
- New Data Highlighting Abraxane as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be Presented at ASCO
- Innovive Pharmaceuticals to Present Interim Data from Phase I Study of INNO-406 at the American Society of Clinical Oncology Annual Meeting
- Celldex Therapeutics Announces Poster Presentations of Lead Product Candidates at ASCO Annual Meeting
- Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
- Celsion Completes Enrollment in Phase I Liver Cancer Study
- Inovio Biomedical to Present at American Society of Gene Therapy Meeting
- Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation
- Data from Rexahn Pharmaceuticals' Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago
May 31, 2007
- Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO Annual Meeting
- Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at the American Headache Society Meeting
- AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy
- Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard Researcher
- Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
- Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
- Data Published in the New England Journal of Medicine Showed Torisel Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma
- IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
- Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
- OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO
- Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
- LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro
- Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
- Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
- New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
- Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
- Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
- Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
- Medicure's MEND-CABG Trial Results Published in Peer Reviewed Journal
- PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin
- Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
